Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2009, Article ID 738293, 3 pages
http://dx.doi.org/10.1155/2009/738293
Case Report

Rituximab Efficacy during a Refractory Polyarteritis Nodosa Flare

1Service de Médecine Interne, Hôpital Saint-André, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
2Service de Médecine Interne et Maladies Infectieuses, Hôpital Haut-Lévêque, Centre Hospitalier Universitaire de Bordeaux, Pessac, France
3Service d'Exploration Fonctionnelle du Système Nerveux, Hôpital Pellegrin, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
4Laboratoire d'Anatomo-Pathologie, Hôpital Pellegrin, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
5Université Victor-Segalen Bordeaux 2, 146, rue Léo-Saignant, 33076 Bordeaux Cedex, France

Received 4 August 2009; Accepted 30 December 2009

Academic Editor: Kenneth C. Kalunian

Copyright © 2009 Emmanuel Ribeiro et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Sibilia and C. Sordet, “Le rituximab: une biothérapie originale dans les maladies auto-immunes,” Revue de Médecine Interne, vol. 26, no. 61, pp. 485–500, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. K. A. Keogh, M. E. Wylam, J. H. Stone, and U. Specks, “Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis,” Arthritis and Rheumatism, vol. 52, no. 1, pp. 262–268, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Sonomoto, T. Miyamura, H. Watanabe et al., “A case of polyarteritis nodosa successfully treated by rituximab,” Nihon Rinsho Meneki Gakkai Kaishi, vol. 31, no. 2, pp. 119–123, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Eleftheriou, M. Melo, S. D. Marks et al., “Biologic therapy in primary systemic vasculitis of the young,” Rheumatology, vol. 48, no. 8, pp. 978–986, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. N. J. Goodson, N. J. Wiles, M. Lunt, E. M. Barrett, A. J. Silman, and D. P. M. Symmons, “Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients,” Arthritis and Rheumatism, vol. 46, no. 8, pp. 2010–2019, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Aranow and E. M. Ginzler, “Epidemiology of cardiovascular disease in systemic lupus erythematosus,” Lupus, vol. 9, no. 3, pp. 166–169, 2000. View at Google Scholar · View at Scopus
  7. S. Manzi, E. N. Meilahn, J. E. Rairie et al., “Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study,” American Journal of Epidemiology, vol. 145, no. 5, pp. 408–415, 1997. View at Google Scholar · View at Scopus
  8. G. Chironi, C. Pagnoux, A. Simon et al., “Increased prevalence of subclinical atherosclerosis in patients with small-vessel vasculitis,” Heart, vol. 93, no. 1, pp. 96–99, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Seyahi, S. Ugurlu, R. Cumali et al., “Atherosclerosis in Takayasu arteritis,” Annals of the Rheumatic Diseases, vol. 65, no. 9, pp. 1202–1207, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. K. De Leeuw, J. S. Sanders, C. Stegeman, A. Smit, C. G. Kallenberg, and M. Bijl, “Accelerated atherosclerosis in patients with Wegener's granulomatosis,” Annals of the Rheumatic Diseases, vol. 64, no. 5, pp. 753–759, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. P. A. Bacon, “Endothelial cell dysfunction in systemic vasculitis: new developments and therapeutic prospects,” Current Opinion in Rheumatology, vol. 17, no. 1, pp. 49–55, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. G. K. Hansson, “Mechanisms of disease: inflammation, atherosclerosis, and coronary artery disease,” The New England Journal of Medicine, vol. 352, no. 16, pp. 1685–1695, 2005. View at Publisher · View at Google Scholar · View at Scopus